Medicare covers testosterone replacement therapy only for medically diagnosed hypogonadism with documented symptoms and low testosterone levels below 300 ng/dL on two separate tests. Coverage requires prior authorization and typically covers 80% of costs after the Part B deductible of $240 in 2026. Medicare Part D may cover testosterone gels and patches with copays ranging from $30-150 per month depending on your plan. Injectable testosterone cypionate through Medicare Part B averages $45-80 per injection when administered in a clinical setting. Medicare Advantage plans often provide enhanced coverage with lower copays, sometimes reducing monthly costs to $15-40. However, Medicare excludes coverage for testosterone therapy prescribed solely for age-related decline, wellness purposes, or muscle building without documented hypogonadism symptoms.
- Medicare requires documented hypogonadism diagnosis with testosterone levels below 300 ng/dL
- Coverage includes 80% of approved treatments after meeting the $240 Part B deductible
- Prior authorization is mandatory for all testosterone replacement therapies
- Injectable testosterone through Part B costs $45-80 per injection in clinical settings
- Alternative therapies like peptide therapy may require out-of-pocket payment
Medicare Coverage Requirements for Testosterone Replacement Therapy
Medicare establishes strict medical criteria for testosterone replacement therapy coverage that extends beyond simple low testosterone readings. Your healthcare provider must document primary or secondary hypogonadism through full testing, including two separate morning testosterone measurements below 300 ng/dL taken at least one week apart. The Centers for Medicare & Medicaid Services requires evidence of hypogonadal symptoms such as decreased libido, erectile dysfunction, fatigue, or mood changes that correlate with laboratory findings. Prior authorization becomes mandatory for all testosterone formulations under Medicare coverage. Your doctor must submit documentation proving medical necessity, including symptom assessments, physical examination findings, and laboratory results. Medicare reviews each case individually, and approval typically takes 5-10 business days. Patients with testosterone levels between 300-400 ng/dL may face additional scrutiny and require more extensive documentation to justify treatment necessity.Medicare Part B and Part D Coverage Differences
Medicare Part B covers injectable testosterone cypionate and enanthate when administered in approved clinical settings, treating these as medical procedures rather than prescription medications. After meeting your annual deductible of $240, Medicare pays 80% of the Medicare-approved amount, leaving you responsible for the remaining 20% plus any provider charges above Medicare's approved rates. Monthly injection costs typically range from $45-80 per treatment session. Medicare Part D handles testosterone gels, patches, and other self-administered formulations as prescription drugs. Coverage varies significantly between Part D plans, with formulary placement affecting your out-of-pocket costs. Testosterone gels like AndroGel or Testim may require step therapy, where you must try less expensive alternatives first. Monthly copays range from $30-150 depending on your specific Part D plan and whether the medication falls into a preferred or non-preferred tier.Medicare Advantage and Supplemental Coverage Options
Medicare Advantage plans often provide enhanced testosterone replacement therapy coverage compared to Original Medicare, with some plans offering $15-40 monthly copays for preferred testosterone formulations. These plans may also cover additional hormone-related services like specialized endocrinology consultations or enhanced laboratory monitoring that Original Medicare limits. Medigap policies help cover the 20% coinsurance gap for Part B-covered testosterone injections, potentially reducing your out-of-pocket expenses to zero for approved treatments. However, Medigap plans cannot enhance Part D prescription drug coverage for self-administered testosterone preparations. Consider exploring Sermorelin or other growth hormone-releasing peptides as alternative approaches, though these typically require private pay arrangements.Frequently Asked Questions
Does Medicare cover testosterone therapy for aging-related low testosterone?
Medicare does not cover testosterone replacement therapy for age-related testosterone decline or "andropause" without documented hypogonadism. You must have testosterone levels below 300 ng/dL with corresponding symptoms and a medical diagnosis of primary or secondary hypogonadism. Wellness-focused testosterone therapy requires private payment, typically costing $200-400 monthly for thorough treatment programs.
See transparent compounded pricing
Review compounded medication pricing and what provider-reviewed care includes, with no surprises at checkout.
Try the Cost Calculator →View data table
| Category | Relative Cost Index | Detail |
|---|---|---|
| Brand Ozempic | 95 | $900-1,350/mo without insurance |
| Brand Wegovy | 90 | $1,300-1,600/mo without insurance |
| Brand Mounjaro | 88 | $1,000-1,200/mo without insurance |
| Compounded | 25 | $299-449/mo at FormBlends |
What documentation does Medicare require for TRT approval?
Medicare requires two separate morning testosterone measurements below 300 ng/dL, detailed symptom documentation, physical examination findings consistent with hypogonadism, and medical history ruling out reversible causes of low testosterone. Your provider must also document failed or inappropriate alternative treatments and provide detailed treatment plans with monitoring protocols for prior authorization approval.
Are there Medicare-covered alternatives to traditional testosterone therapy?
Medicare may cover clomiphene citrate for younger men with secondary hypogonadism, as this medication can stimulate natural testosterone production. Human chorionic gonadotropin (hCG) injections receive limited coverage for specific hypogonadal conditions. However, newer treatments like BPC-157 or TB-500 peptides remain experimental and require private payment arrangements.
How much will I pay out-of-pocket for Medicare-covered TRT?
After meeting the $240 Part B deductible, you'll pay 20% of Medicare-approved amounts for injectable testosterone, typically $10-20 per injection. Part D prescription copays vary by plan but average $30-80 monthly for testosterone gels or patches. Medicare Advantage plans may reduce these costs to $15-40 monthly, while Medigap policies can eliminate Part B coinsurance entirely.
Can Medicare deny coverage for medically necessary testosterone therapy?
Medicare can deny coverage if documentation doesn't meet medical necessity criteria, testosterone levels exceed 300 ng/dL, or symptoms don't correlate with hypogonadal diagnosis. Denials often occur when providers fail to rule out reversible causes like medications, obesity, or sleep disorders. You can appeal Medicare decisions through a formal review process that typically takes 30-60 days for resolution.
Sources
- Centers for Medicare & Medicaid Services. Medicare Coverage Guidelines for Testosterone Replacement Therapy. CMS Manual Publication 100-03, Section 210.2. Updated January 2026.
- Bhasin S, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism. 2018;103(5):1715-1744. PMID: 29562364.
- Medicare Part D Prescription Drug Coverage Analysis. 2026 Formulary Review of Testosterone Preparations. Medicare.gov Resource Center. March 2026.
- Mulhall JP, et al. Evaluation and management of testosterone deficiency: AUA guideline. Journal of Urology. 2018;200(2):423-432. PMID: 29601923.
- Medicare Advantage Plan Performance Data. Hormone Replacement Therapy Coverage Analysis 2024-2026. Centers for Medicare & Medicaid Services Statistical Report.
- Corona G, et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. European Journal of Endocrinology. 2011;165(5):687-701. PMID: 21852391.
- Medicare Appeals Process for Hormone Therapy Denials. Administrative Law Judge Decision Database 2025-2026. Social Security Administration Healthcare Appeals Division.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →